Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Adverse events in the placebo arm of SOLO2/ENGOT-Ov21 maintenance trial of olaparib in recurrent ovarian cancer.

Autor: Francis KE; National Health and Medical Research Council Clinical Trials Centre, The University of Sydney, Sydney, NSW 2050, Australia; Department of Medical Oncology, Wollongong Hospital, Wollongong, NSW 2500, Australia. Electronic address: katherine.francis@sydney.edu.au., Simon S; National Health and Medical Research Council Clinical Trials Centre, The University of Sydney, Sydney, NSW 2050, Australia., Gebski V; National Health and Medical Research Council Clinical Trials Centre, The University of Sydney, Sydney, NSW 2050, Australia., Joly F; Group d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), Paris, France; Centre Francois Baclesse, Caen, France., Ledermann JA; UCL Cancer Institute and UCL Cancer Trials Centre, NCRI UK, London, UK., Penson RT; Harvard Medical School, Massachusetts General Hospital, Boston, USA., Oza AM; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada., Korach J; Sheba Medical Center, Tel Aviv University, Tel Hashomer, Israel., Lainez N; Navarra University Hospital, GEICO, Pamplona, Spain., Cecere SC; Oncologia Clinica Sperimentale Uro-Ginecologica, Istituto Nazionale Tumori - IRCCS- Fondazione G.Pascale, Napoli and MITO Italia, Napoli, Italy., Tasca G; Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy., Gropp-Meier M; Arbeitsgemeinschaft Gynäkologische Onkologie Studiengruppe, (AGO), Germany; Onkologie Ravensburg, Ravensburg, Germany., Fujiwara K; Department of Gynecologic Oncology, Saitama Medical University International Medical Center, Hidaka, Saitama, Japan., Lowe ES; Global Medicines Development, Oncology, AstraZeneca, Gaithersburg, MD, USA., Friedlander M; School of Clinical Medicine, UNSW, Sydney, Australia; Department of Medical Oncology, Prince of Wales and Royal Hospital for Women, Randwick, NSW, Australia., Pujade-Lauraine E; ARCAGY-GINECO Université Paris Descartes, AP-HP, Paris, France., Lee CK; National Health and Medical Research Council Clinical Trials Centre, The University of Sydney, Sydney, NSW 2050, Australia; Department of Medical Oncology, St George Hospital, Kogarah, NSW 2217, Australia.

Publikováno v: Gynecologic oncology [Gynecol Oncol] 2024 Nov 12; Vol. 192, pp. 50-55. Date of Electronic Publication: 2024 Nov 12.